Skip to main content

#154801

Anti-Thyroglobulin [2H11]

Cat. #154801

Anti-Thyroglobulin [2H11]

Cat. #: 154801

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Thyroglobulin

Class: Monoclonal

Application: IHC

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Netherlands Cancer Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Thyroglobulin [2H11]
  • Alternate name: TG; AITD3
  • Research fields: Developmental biology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 660 kDa
  • Host: Mouse
  • Application: IHC
  • Description: Thyroglobulin is a 660 kDa, dimeric protein produced by the follicular cells of the thyroid and used entirely within the thyroid gland. Thyroglobulin protein accounts for approximately half of the protein content of the thyroid gland. Thyroglobulin is used by the thyroid gland to produce the thyroid hormones thyroxine (T4) and triiodothyronine (T3).
  • Isotype: IgG1

Target Details

  • Target: Thyroglobulin
  • Molecular weight: 660 kDa
  • Target background: Thyroglobulin is a 660 kDa, dimeric protein produced by the follicular cells of the thyroid and used entirely within the thyroid gland. Thyroglobulin protein accounts for approximately half of the protein content of the thyroid gland. Thyroglobulin is used by the thyroid gland to produce the thyroid hormones thyroxine (T4) and triiodothyronine (T3).

Applications

  • Application: IHC

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Heffess et al. 2002. Cancer. 95(9):1869-78. PMID: 12404280.
  • Judkins et al. 1999. Hum Pathol. 30(11):1373-6. PMID: 10571520.
  • Bellet et al. 1983. J Clin Endocrinol Metab. 56(3):530-3. PMID: 6185526.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.